Unbiased Analysis of Today's Healthcare Issues
According to a paper by Smith et al. 2023, the answer is ‘no’. The authors use data from AHRQ’s Healthcare Cost and Utilization Project (HCUP) State Inpatient Data, Hospital Cost Reporting Information System Data, Office of Pharmacy Affairs Information System Data, and American Hospital Association Annual Survey for 15 states between 2008 to 2014. The…
Last month, FDA released guidance on the use of real-world evidence to support regulatory decision-making for new drugs. Below are some of the key points from this guidance document: Legislative mandate. The 21st Century Cures Act (Cures Act), signed December 2016, mandated that the FDA consider how to incorporate real world data (RWD) into regulator…
James Chambers has put together a series of papers looking at health gains (and cost effectiveness) using the Tufts Cost Effectiveness Analysis Registry. In these studies , he finds that treatments for rare diseases, specialty drugs, and those that receive expedited review are more likely to provide the largest health benefit (≥0.9 QALYs gained versus…
Biosimilar “skinny labels” Expensive generics? EU to ban payment for milk, sperm and blood Google Health on AI. Victor Fuchs has passed away..
How did the number of pediatrician and family medicine physician (FMP) change between 2010 and 2020, particularly for rural areas? A paper by Ramesh and Yu (2023) use data from the Health Resources and Services Administration (HRSA) Area Health Resources Files and and county characteristics from the American Community Survey and find that: From 2010…
The answer is health plans according to a new paper by Sen, Chang and Hargraves (2023): Using the Health Care Cost Institute’s data set of claims for one-third of the US population with employer-sponsored insurance, we found that unadjusted prices were higher in self-insured plans for most of the services we studied, with the largest…
That is the title of an interesting review paper by Squires et al. 2023. The abstract is below: The effectiveness and cost of a public health intervention is dependent on complex human behaviors, yet health economic models typically make simplified assumptions about behavior, based on little theory or evidence. This paper reviews existing methods across…
Perhaps according to a report from Stat News: A groundbreaking clause in a new deal between the Department of Health and Human Services and the pharmaceutical company Regeneron marks the first time the Biden administration has directly used its leverage to challenge drugmakers’ list prices, experts told STAT.The contract between Regeneron and the government requires…
Excess mortality in China after ending “Zero COVID” Responsiveness to private health insurance subsidies among the elderly. power=0.06 New COVID vaccines for all. ChatGPT made zero “grossly inaccurate” statements when presented with a standard set of eye complaints.
Health care data–particularly spending data–often has a right skewed distribution with a high number of 0’s. For instance, US health care spending in 2019 was $11,852. However, many people don’t get sick and have no health care spending. Moreover, people generally don’t have negative health care spending. Further, some many patients with serious diseases rack…